Recommendations for Diagnosis and Management of Osteoporosis in COPD Men

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis and fractures because of lifestyle factors, systemic effects of the disease, side effects of treatment, and comorbidities. The initial evaluation of COPD men for osteoporosis must include a detailed med...

Full description

Saved in:
Bibliographic Details
Published in:ISRN rheumatology 2011-01, Vol.2011 (2011), p.1-8
Main Authors: Mazokopakis, Elias E., Starakis, Ioannis K.
Format: Article
Language:English
Subjects:
Bone density
Bones
Mortality
Older people
Osteoporosis
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3
cites cdi_FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3
container_end_page 8
container_issue 2011
container_start_page 1
container_title ISRN rheumatology
container_volume 2011
creator Mazokopakis, Elias E.
Starakis, Ioannis K.
description Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis and fractures because of lifestyle factors, systemic effects of the disease, side effects of treatment, and comorbidities. The initial evaluation of COPD men for osteoporosis must include a detailed medical history and physical examination, assessment of COPD severity, and additional tests, as suggested by results of clinical evaluation. Osteoporosis is diagnosed on the basis of bone mineral density (BMD) measurement with DEXA of the lumbar spine and hip, but fracture risk assessments tools, as FRAX, could be used as useful supplements to BMD assessments for therapeutics interventions. The prevention and treatment of osteoporosis in COPD involves nonpharmacologic and pharmacologic measures, as lifestyle measures and nutritional recommendations, management of COPD treatment (based on the use of limited corticosteroids doses), and drug therapy (bisphosphonates, teriparatide). In this paper, the current recommendations for diagnosis and management of osteoporosis in COPD men, based on recent medical bibliography, are presented and discussed.
doi_str_mv 10.5402/2011/901416
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3263743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>926506716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3</originalsourceid><addsrcrecordid>eNqFkUtrGzEUhUVpqI3jVdYtQzcNCW70GL02gWLnUXBwKelayLLGlvFIzshOyL_PdSY1aReJNhK6H4dzz0HoiODvvMT0jGJCzjQmJREfUJdijQe8lPzj_i1kB_VzXmI4AnOu5CfUoZQprTDvouvf3qW69nFmNyHFXFSpKUbBzmPKIRc2zoobG-3cA7IpUlVM8sandWqexyEWw8mvUXHj4yE6qOwq-_7L3UN_Li9uh9eD8eTq5_DHeOBYScXAY1qBMUYJ1YyUwnnJOLNKcyKcJoJRVenpFMwRrIgQSsI3Y5xKrRxjjvXQeau73k5rP3Ngq7Ers25CbZtHk2ww_05iWJh5ujeMCiZLBgLfXgSadLf1eWPqkJ1frWz0aZuNpoJjIcFKDx2_SRIJbqmmfCf69T90mbZNhCBAjyoutN7pnbaQg_Ry46u9a4LNrk2za9O0bQL95fWie_ZvdwCctMAiQHsP4R21zy3sAfGV3cOwK4dUngCNtayW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>922856996</pqid></control><display><type>article</type><title>Recommendations for Diagnosis and Management of Osteoporosis in COPD Men</title><source>PubMed Central</source><creator>Mazokopakis, Elias E. ; Starakis, Ioannis K.</creator><contributor>Gennari, L.</contributor><creatorcontrib>Mazokopakis, Elias E. ; Starakis, Ioannis K. ; Gennari, L.</creatorcontrib><description>Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis and fractures because of lifestyle factors, systemic effects of the disease, side effects of treatment, and comorbidities. The initial evaluation of COPD men for osteoporosis must include a detailed medical history and physical examination, assessment of COPD severity, and additional tests, as suggested by results of clinical evaluation. Osteoporosis is diagnosed on the basis of bone mineral density (BMD) measurement with DEXA of the lumbar spine and hip, but fracture risk assessments tools, as FRAX, could be used as useful supplements to BMD assessments for therapeutics interventions. The prevention and treatment of osteoporosis in COPD involves nonpharmacologic and pharmacologic measures, as lifestyle measures and nutritional recommendations, management of COPD treatment (based on the use of limited corticosteroids doses), and drug therapy (bisphosphonates, teriparatide). In this paper, the current recommendations for diagnosis and management of osteoporosis in COPD men, based on recent medical bibliography, are presented and discussed.</description><identifier>ISSN: 2090-5467</identifier><identifier>EISSN: 2090-5475</identifier><identifier>DOI: 10.5402/2011/901416</identifier><identifier>PMID: 22389805</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Bone density ; Bones ; Mortality ; Older people ; Osteoporosis ; Review</subject><ispartof>ISRN rheumatology, 2011-01, Vol.2011 (2011), p.1-8</ispartof><rights>Copyright © 2011 Elias E. Mazokopakis and Ioannis K. Starakis.</rights><rights>Copyright © 2011 Elias E. Mazokopakis and Ioannis K. Starakis. Elias E. Mazokopakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2011 E. E. Mazokopakis and I. K. Starakis. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3</citedby><cites>FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263743/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263743/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22389805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Gennari, L.</contributor><creatorcontrib>Mazokopakis, Elias E.</creatorcontrib><creatorcontrib>Starakis, Ioannis K.</creatorcontrib><title>Recommendations for Diagnosis and Management of Osteoporosis in COPD Men</title><title>ISRN rheumatology</title><addtitle>ISRN Rheumatol</addtitle><description>Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis and fractures because of lifestyle factors, systemic effects of the disease, side effects of treatment, and comorbidities. The initial evaluation of COPD men for osteoporosis must include a detailed medical history and physical examination, assessment of COPD severity, and additional tests, as suggested by results of clinical evaluation. Osteoporosis is diagnosed on the basis of bone mineral density (BMD) measurement with DEXA of the lumbar spine and hip, but fracture risk assessments tools, as FRAX, could be used as useful supplements to BMD assessments for therapeutics interventions. The prevention and treatment of osteoporosis in COPD involves nonpharmacologic and pharmacologic measures, as lifestyle measures and nutritional recommendations, management of COPD treatment (based on the use of limited corticosteroids doses), and drug therapy (bisphosphonates, teriparatide). In this paper, the current recommendations for diagnosis and management of osteoporosis in COPD men, based on recent medical bibliography, are presented and discussed.</description><subject>Bone density</subject><subject>Bones</subject><subject>Mortality</subject><subject>Older people</subject><subject>Osteoporosis</subject><subject>Review</subject><issn>2090-5467</issn><issn>2090-5475</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkUtrGzEUhUVpqI3jVdYtQzcNCW70GL02gWLnUXBwKelayLLGlvFIzshOyL_PdSY1aReJNhK6H4dzz0HoiODvvMT0jGJCzjQmJREfUJdijQe8lPzj_i1kB_VzXmI4AnOu5CfUoZQprTDvouvf3qW69nFmNyHFXFSpKUbBzmPKIRc2zoobG-3cA7IpUlVM8sandWqexyEWw8mvUXHj4yE6qOwq-_7L3UN_Li9uh9eD8eTq5_DHeOBYScXAY1qBMUYJ1YyUwnnJOLNKcyKcJoJRVenpFMwRrIgQSsI3Y5xKrRxjjvXQeau73k5rP3Ngq7Ers25CbZtHk2ww_05iWJh5ujeMCiZLBgLfXgSadLf1eWPqkJ1frWz0aZuNpoJjIcFKDx2_SRIJbqmmfCf69T90mbZNhCBAjyoutN7pnbaQg_Ry46u9a4LNrk2za9O0bQL95fWie_ZvdwCctMAiQHsP4R21zy3sAfGV3cOwK4dUngCNtayW</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Mazokopakis, Elias E.</creator><creator>Starakis, Ioannis K.</creator><general>Hindawi Puplishing Corporation</general><general>International Scholarly Research Network</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QP</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Recommendations for Diagnosis and Management of Osteoporosis in COPD Men</title><author>Mazokopakis, Elias E. ; Starakis, Ioannis K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bone density</topic><topic>Bones</topic><topic>Mortality</topic><topic>Older people</topic><topic>Osteoporosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazokopakis, Elias E.</creatorcontrib><creatorcontrib>Starakis, Ioannis K.</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ISRN rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazokopakis, Elias E.</au><au>Starakis, Ioannis K.</au><au>Gennari, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations for Diagnosis and Management of Osteoporosis in COPD Men</atitle><jtitle>ISRN rheumatology</jtitle><addtitle>ISRN Rheumatol</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>2011</volume><issue>2011</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>2090-5467</issn><eissn>2090-5475</eissn><abstract>Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for osteoporosis and fractures because of lifestyle factors, systemic effects of the disease, side effects of treatment, and comorbidities. The initial evaluation of COPD men for osteoporosis must include a detailed medical history and physical examination, assessment of COPD severity, and additional tests, as suggested by results of clinical evaluation. Osteoporosis is diagnosed on the basis of bone mineral density (BMD) measurement with DEXA of the lumbar spine and hip, but fracture risk assessments tools, as FRAX, could be used as useful supplements to BMD assessments for therapeutics interventions. The prevention and treatment of osteoporosis in COPD involves nonpharmacologic and pharmacologic measures, as lifestyle measures and nutritional recommendations, management of COPD treatment (based on the use of limited corticosteroids doses), and drug therapy (bisphosphonates, teriparatide). In this paper, the current recommendations for diagnosis and management of osteoporosis in COPD men, based on recent medical bibliography, are presented and discussed.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>22389805</pmid><doi>10.5402/2011/901416</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2090-5467
ispartof ISRN rheumatology, 2011-01, Vol.2011 (2011), p.1-8
issn 2090-5467
2090-5475
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3263743
source PubMed Central
subjects Bone density
Bones
Mortality
Older people
Osteoporosis
Review
title Recommendations for Diagnosis and Management of Osteoporosis in COPD Men
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A49%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20for%20Diagnosis%20and%20Management%20of%20Osteoporosis%20in%20COPD%20Men&rft.jtitle=ISRN%20rheumatology&rft.au=Mazokopakis,%20Elias%20E.&rft.date=2011-01-01&rft.volume=2011&rft.issue=2011&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=2090-5467&rft.eissn=2090-5475&rft_id=info:doi/10.5402/2011/901416&rft_dat=%3Cproquest_pubme%3E926506716%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3426-e02f090321293146ce7353a89516c916328f9bb980108166876c93352798c33c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=922856996&rft_id=info:pmid/22389805&rfr_iscdi=true